Bortezomib Completed Phase 1 Trials for Colorectal Cancers / Renal Cancers / Unspecified Adult Solid Tumor, Protocol Specific / Sarcomas / Lung Cancers / Breast Cancer / Malignant Neoplasm of Pancreas / Head and Neck Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00290680Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors
NCT00622674Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
NCT00541359Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors
NCT00007878Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
NCT00030368Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00028587PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00023855PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors
NCT00027898Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00068484A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies
NCT00227513Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00388089Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors
NCT00280176Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer
NCT00098982Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT00629226Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer